Back to search
Anemia in End Stage Renal Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anemia in End Stage Renal Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anemia in End Stage Renal Disease trials you may qualify forRoxadustat is a licensed medicine to treat anemia in adults with chronic kidney disease (CKD). Anemia is a low level of red blood cells. Current treatment for a…
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
Patients with kidney failure who require hemodialysis often suffer from anemia (low red blood cell count), heart and blood vessel problems, and a condition invo…
People with severe kidney failure who need regular hemodialysis treatment often experience several health problems. These include anemia (low red blood cell cou…
The goal of this clinical trial is to find out which method is better for guiding iron treatment in adult patients with end-stage kidney disease (ESKD) on hemod…
Hemolytic and uremic syndrome (HUS) is a clinic-biological syndrome related to thrombotic microangiopathy affecting predominantly the kidney. Atypical HUS (aHUS…
Renal anemia is common in people receiving long-term hemodialysis and is usually treated with erythropoiesis-stimulating agents (ESAs). Some patients respond po…
The human intestinal tract harbours a diverse and complex microbial community which plays a central role in human health. It has been estimated that our gut con…
The study will assess role of rule based algorithm in anemia management in hemodialysis patients and its relation to patient's mortality